Table 2.

Symptom variability between Continuous OC compared to cyclic and non-OC groups

For each outcome evaluated, the first row presents data on the Continuous OC users. The second row presents comparisons between Continuous and Cyclic OC users, and the third row presents comparisons between Continuous OC users and non-OC users. Rows with significant differences relative to Continuous OCs are shaded in gray.

	Groups	Mean	Std. Deviation	P value*	Barlett’s test**
MFIS	Cont.	3.44	1.68
	OC
	Cyclic	5.05	1.63	0.000	0.818
	OC
	No OC	4.24	1.80	0.001	0.435
Hassles	Cont.	0.79	0.30
	OC
	Cyclic	0.93	0.18	0.000	0.000
	OC
	No OC	0.88	0.29	0.011	0.680
PHQ9	Cont.	1.20	011
	OC
	Cyclic	2.30	1.42	0.000	0.000
	OC
	No OC	1.89	1.05	0.000	0.000
SymptoMScreen	Cont.	1.22	0.47
	OC
	Cyclic	2.49	0.72	0.000	0.000
	OC
	No OC	2.14	1.15	0.000	0.000
PSS10	Cont.	1.85	0.66
	OC
	Cyclic	1.96	0.39	0.111	0.000
	OC
	No OC	2.47	1.30	0.000	0.000
Uplift	Cont.	0.87	0.08
	OC
	Cyclic	0.84	0.25	0.395	0.000
	OC
	No OC	0.82	0.32	0.199	0.000

^*p-value in comparison with Cont. OC users, derived from ANOVA where p ≤ 0.05 represents that the score means are significantly different between the groups.

^**p-value in comparison with Cont. OC users, derived from Bartlett’s test for homogeneity of variances where p > 0.05 represents that the score variance is significantly different between the groups.